Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Medtronic
Merck
Harvard Business School
Johnson and Johnson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Benazepril hydrochloride; hydrochlorothiazide - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for benazepril hydrochloride; hydrochlorothiazide and what is the scope of patent protection?

Benazepril hydrochloride; hydrochlorothiazide is the generic ingredient in two branded drugs marketed by Ani Pharms Inc, Apotex Inc, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Ltd, and Us Pharms Holdings I, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for benazepril hydrochloride; hydrochlorothiazide. Ten suppliers are listed for this compound.

Summary for benazepril hydrochloride; hydrochlorothiazide
Recent Clinical Trials for benazepril hydrochloride; hydrochlorothiazide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
TSH Biopharm Corporation LimitedPhase 4
Ranbaxy Laboratories LimitedN/A

See all benazepril hydrochloride; hydrochlorothiazide clinical trials

Pharmacology for benazepril hydrochloride; hydrochlorothiazide

US Patents and Regulatory Information for benazepril hydrochloride; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 077483-003 Sep 8, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 076612-004 Feb 11, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Apotex Inc BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 078794-004 Aug 21, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Inc BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 078794-001 Aug 21, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Inc BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 078794-002 Aug 21, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for benazepril hydrochloride; hydrochlorothiazide

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Colorcon
Baxter
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.